Hemagen Diagnostics Inc. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2008
2009
2010
2011
2012
Cash & Short Term Investments
98.80
156.30
151.70
213.60
66.30
Total Accounts Receivable
1,076.30
840.00
879.90
615.20
587.50
Inventories
2,037.00
1,703.20
1,386.30
1,460.80
1,363.10
Other Current Assets
304.00
120.50
352.50
159.50
77.90
Total Current Assets
3,516.20
2,820.00
2,770.50
2,449.10
2,094.70
Net Property, Plant & Equipment
697.10
599.00
525.70
386.50
282.30
Long-Term Note Receivable
455.00
245.00
35.00
-
-
Other Assets
98.10
54.30
40.30
52.70
65.70
Total Assets
4,766.30
3,718.30
3,371.40
2,888.30
2,442.70
ST Debt & Current Portion LT Debt
4,511.50
428.90
398.00
669.40
976.90
Accounts Payable
735.50
560.10
308.60
415.20
951.80
Income Tax Payable
-
99.10
-
-
-
Other Current Liabilities
494.80
361.80
461.90
440.90
21.00
Total Current Liabilities
5,741.80
1,449.80
1,168.50
1,525.50
1,949.70
Long-Term Debt
119.50
4,049.90
4,049.90
4,049.90
4,049.90
Total Liabilities
5,861.30
5,499.70
5,218.40
5,575.40
5,999.50
Common Equity (Total)
1,094.90
1,781.40
1,847.00
2,687.10
3,556.80
Total Shareholders' Equity
1,094.90
1,781.40
1,847.00
2,687.10
3,556.80
Total Equity
1,094.90
1,781.40
1,847.00
2,687.10
3,556.80
Liabilities & Shareholders' Equity
4,766.30
3,718.30
3,371.40
2,888.30
2,442.70
About Hemagen Diagnostics
View Profile
